【新研究】每天吃兩頓飯在血糖控製上有優勢.但需進一步證實

來源: 2014-05-20 13:29:33 [博客] [舊帖] [給我悄悄話] 本文已被閱讀:


【BBC News】科學家發現,每天吃兩頓飯(僅早餐和午餐,富含蔬菜、水果和纖維)的2型糖尿病患者,在血糖控製水平上優於少量多餐者(每天6頓飯)。此研究可能也適用於無糖尿病的想減肥者。不過仍需大型和隨訪時間更長的臨床研究證實,不好隨便套用哦。這項研究一共54人參加,分成兩組,每組各27人,曆時三個月(12個星期)。
 

Two meals a day 'effective' to treat type 2 diabetes

http://www.bbc.com/news/health-27422547
Vegetables and fruit
Scientists prescribed two meals a day rich in fruit, vegetables and fibre


Only eating breakfast and lunch may be more effective at managing type 2 diabetes than eating smaller, more regular meals, scientists say.

Researchers in Prague fed two groups of 27 people the same calorie diet spread over two or six meals a day.

They found volunteers who ate two meals a day lost more weight than those who ate six, and their blood sugar dropped.

Experts said the study supported "existing evidence" that fewer, larger meals were the way forward.

Only eating breakfast and lunch may be more effective at managing type 2 diabetes than eating smaller, more regular meals, scientists say.

Researchers in Prague fed two groups of 27 people the same calorie diet spread over two or six meals a day.

They found volunteers who ate two meals a day lost more weight than those who ate six, and their blood sugar dropped.

Experts said the study supported "existing evidence" that fewer, larger meals were the way forward.

Timing important?

Type 2 diabetes occurs when the body does not produce enough of the hormone insulin to function properly, or the body's cells don't react to insulin.

Since insulin controls the amount of sugar in the blood, this means blood sugar levels become too high.

If untreated, it can lead to heart disease and stroke, nerve damage, light-sensitive eyes and kidney disease.

About 2.9 million people in the UK are affected by diabetes, 90% of whom have the type 2 form of the disease.

Current advice in the UK recommends three meals a day, with healthy snacks.

Scientists at the Institute for Clinical and Experimental Medicine in Prague divided a group of 54 volunteers aged 30 to 70 with type 2 diabetes into two groups of 27 people.

Volunteers were then given either a six-meal-a-day diet (A6) for 12 weeks followed by a two-meal day diet (B2), or vice versa.

The study compared two meals with six meals - as the latter accorded with current practice advice in the Czech Republic, researchers said.

Each diet contained on average 1,700 calories a day.

'Very pleasing' result

The B2 group ate between 06:00 and 10:00 and then between 12:00 and 16:00, and the A6 group ate their food throughout the day.

Weight loss for the B2 group averaged 1.4kg (3lb) more than A6, and they lost about 4cm (1.5in) more from their waistlines.

Lead scientist Dr Hana Kahleova, at the Institute for Clinical and Experimental Medicine, said the results were "very pleasing".

She said: "The patients were really afraid they would get hungry in the evening but feelings of hunger were lower as the patients ate until they were satisfied.

"But when they ate six times a day the meals were not leaving them feeling satisfied. It was quite surprising."

'Larger studies needed'

Dr Kahleova said the study could apply to people without diabetes who were trying to lose weight.

Dr Richard Elliott, research communications officer at Diabetes UK, said the study added to evidence that eating fewer, larger meals a day could be more effective than smaller, frequent meals at helping people manage their condition.

He added: "However, larger studies over longer periods of time will be needed to back up these findings before we would make changes to the dietary advice given to people with type 2 diabetes."

Dr Elliot said eating a healthy, balanced diet, being active and maintaining a healthy weight, alongside taking any medication was "vital" to effectively manage the condition.

 

【警鍾: Actos(艾可拓)可能引發膀胱癌】4月8日,美國路易斯安那州法院陪審團判決日本最大藥企武田製藥因涉嫌隱瞞糖尿病用藥艾可拓Actos(吡格列酮)可能引發的膀胱癌等安全性風險,需支付懲罰性賠償金60億美元。其實自此之前,艾可拓已經收到藥物安全警告。

http://www.bloomberg.com/news/2014-04-07/takeda-actos-jury-awards-6-billion-in-punitive-damages.html

Photographer: Kiyoshi Ota/Bloomberg

The Takeda Pharmaceutical Co. logo is displayed atop the company's head office in Tokyo.